Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their due

Ex vivo feeder-free autologous NK cell expansion is an efficient modality for clinical translation. In this issue of Cell Reports Medicine, Nahi et al. describe the use of this approach as consolidation therapy for multiple myeloma,(1) thereby reviving an alternate avenue for NK cell therapy.

Detalles Bibliográficos
Autores principales: Shapiro, Roman M., Romee, Rizwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Preview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861944/
https://www.ncbi.nlm.nih.gov/pubmed/35243428
http://dx.doi.org/10.1016/j.xcrm.2022.100537
_version_ 1784654964973371392
author Shapiro, Roman M.
Romee, Rizwan
author_facet Shapiro, Roman M.
Romee, Rizwan
author_sort Shapiro, Roman M.
collection PubMed
description Ex vivo feeder-free autologous NK cell expansion is an efficient modality for clinical translation. In this issue of Cell Reports Medicine, Nahi et al. describe the use of this approach as consolidation therapy for multiple myeloma,(1) thereby reviving an alternate avenue for NK cell therapy.
format Online
Article
Text
id pubmed-8861944
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88619442022-03-02 Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their due Shapiro, Roman M. Romee, Rizwan Cell Rep Med Preview Ex vivo feeder-free autologous NK cell expansion is an efficient modality for clinical translation. In this issue of Cell Reports Medicine, Nahi et al. describe the use of this approach as consolidation therapy for multiple myeloma,(1) thereby reviving an alternate avenue for NK cell therapy. Elsevier 2022-02-15 /pmc/articles/PMC8861944/ /pubmed/35243428 http://dx.doi.org/10.1016/j.xcrm.2022.100537 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Preview
Shapiro, Roman M.
Romee, Rizwan
Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their due
title Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their due
title_full Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their due
title_fullStr Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their due
title_full_unstemmed Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their due
title_short Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their due
title_sort autologous cellular therapy for myeloma: giving ex vivo expanded nk cells their due
topic Preview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861944/
https://www.ncbi.nlm.nih.gov/pubmed/35243428
http://dx.doi.org/10.1016/j.xcrm.2022.100537
work_keys_str_mv AT shapiroromanm autologouscellulartherapyformyelomagivingexvivoexpandednkcellstheirdue
AT romeerizwan autologouscellulartherapyformyelomagivingexvivoexpandednkcellstheirdue

Ejemplares similares